ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)
Conditions:   ANCA Associated Vasculitis;   Cardiovascular Diseases;   Kidney Diseases Intervention:   Drug: Sparsentan Sponsors:   University of Edinburgh;   Travere Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2022 Category: Research Source Type: clinical trials

CXCR4-PET/CT in GCA
Conditions:   Vasculitis;   Diagnoses Disease Intervention:   Diagnostic Test: CXCR4-PET Sponsor:   Matthias Fröhlich Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2022 Category: Research Source Type: clinical trials